Article thumbnail

Additional file 1: of Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes

By Emma de Moel (4889761), Veerle Derksen (4358371), Gerrie Stoeken (4889758), Leendert Trouw (3446432), Holger Bang (3567437), Robbert Goekoop (4889767), Irene Speyer (4889764), Tom Huizinga (3398660), Cornelia Allaart (3398666), RenĂŠ Toes (3562775) and Diane van der Woude (3562766)


Figure S1. Agreement between previously determined antibody status and remeasurement by ELISA. Figure S2. Overlap of isotypes and antibodies at baseline. Figure S3. DAS over first year of treatment. Figure S4. Initial change in DAS and DFR outcomes within patients positive for individual antibodies. Figure S5. Association between baseline autoantibody profile and long-term sustained drug-free remission within patients that reached early remission and had outcome data available. (DOCX 1605 kb

Topics: Medicine, Pharmacology, Biotechnology, Immunology, Cancer, Hematology, Computational Biology, Ant-CCP, Rheumatoid arthritis, Rheumatoid factor, Autoantibodies, Disease activity
Year: 2018
DOI identifier: 10.6084/m9.figshare.5927269.v1
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.